Group ACYW135 meningococcal polysaccharide vaccine (Beijing Zhifei Lvzhu)

ACYW135群脑膜炎球菌多糖疫苗（北京智飞绿竹）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameGroup ACYW135 meningococcal polysaccharide vaccine (Beijing Zhifei Lvzhu)
Drug Alias Name盟威克
ClassificationVaccines > Application > Prophylactic vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Biological material > Bacterial vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMeningitisSepsisPneumonia +[6] 
Global Approved IndicationsMeningococcal Infections
Approved Indications in ChinaMeningococcal Infections
Original Approved Country/TerritoryMainland China
Original Approved Date2007/11/15
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBeijing Zhifei Lvzhu Biopharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Zhifei Lvzhu Biopharmaceutical Co LtdBeijing Lvzhu Biological Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsMeningococcal InfectionsMeningitis, Meningococcal
Inactive IndicationsMeningitisSepsisPneumonia +[4] 

Other Information

ATC CodeJ07AH04
Related LinksN/A